Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: a multicentre, open-label, phase 1 study

BACKGROUND: Gene fusions involving NTRK1, NTRK2, or NTRK3 (TRK fusions) are found in a broad range of paediatric and adult malignancies. Larotrectinib, a highly selective small-molecule inhibitor of the TRK kinases, had demonstrated activity in preclinical models and in adults with tumours harbourin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Oncol
Main Authors: Laetsch, Theodore W., DuBois, Steven G., Mascarenhas, Leo, Turpin, Brian, Federman, Noah, Albert, Catherine M., Nagasubramanian, Ramamoorthy, Davis, Jessica L., Rudzinski, Erin, Feraco, Angela M., Tuch, Brian B., Ebata, Kevin T., Reynolds, Mark, Smith, Steven, Cruickshank, Scott, Cox, Michael C., Pappo, Alberto S., Hawkins, Douglas S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5949072/
https://ncbi.nlm.nih.gov/pubmed/29606586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(18)30119-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados